These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27922038)

  • 1. Prostate cancer: Calcium promotes cancer; vitamin D decelerates.
    Fenner A
    Nat Rev Urol; 2017 Feb; 14(2):68. PubMed ID: 27922038
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.
    Atala A
    J Urol; 2018 May; 199(5):1115-1116. PubMed ID: 29677904
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.
    Bernichtein S; Pigat N; Barry Delongchamps N; Boutillon F; Verkarre V; Camparo P; Reyes-Gomez E; Méjean A; Oudard SM; Lepicard EM; Viltard M; Souberbielle JC; Friedlander G; Capiod T; Goffin V
    Cancer Res; 2017 Jan; 77(2):355-365. PubMed ID: 27879271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-Sensing Receptor Stimulation in Cultured Glomerular Podocytes Induces TRPC6-Dependent Calcium Entry and RhoA Activation.
    Zhang L; Ji T; Wang Q; Meng K; Zhang R; Yang H; Liao C; Ma L; Jiao J
    Cell Physiol Biochem; 2017; 43(5):1777-1789. PubMed ID: 29050010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.
    Tokar EJ; Webber MM
    Clin Exp Metastasis; 2005; 22(3):265-73. PubMed ID: 16158254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer.
    Tokar EJ; Ancrile BB; Ablin RJ; Webber MM
    J Exp Ther Oncol; 2006; 5(4):323-33. PubMed ID: 17024972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of TRPC6 on invasibility of low-differentiated prostate cancer cells.
    Wang D; Li X; Liu J; Li J; Li LJ; Qiu MX
    Asian Pac J Trop Med; 2014 Jan; 7(1):44-7. PubMed ID: 24418082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.
    Tokar EJ; Webber MM
    Clin Exp Metastasis; 2005; 22(3):275-84. PubMed ID: 16158255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and intervention trials in prostate cancer: from theory to therapy.
    Schwartz GG
    Ann Epidemiol; 2009 Feb; 19(2):96-102. PubMed ID: 18619854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.
    Szendroi A; Speer G; Tabak A; Kosa JP; Nyirady P; Majoros A; Romics I; Lakatos P
    Can J Urol; 2011 Jun; 18(3):5710-6. PubMed ID: 21703046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race and BMI modify associations of calcium and vitamin D intake with prostate cancer.
    Batai K; Murphy AB; Ruden M; Newsome J; Shah E; Dixon MA; Jacobs ET; Hollowell CM; Ahaghotu C; Kittles RA
    BMC Cancer; 2017 Jan; 17(1):64. PubMed ID: 28103838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
    Brändstedt J; Almquist M; Manjer J; Malm J
    Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and Ki67 labeling in prostate cancer patients." Wagner D, Trudel D, Van der Kwast T, Nonn L, Giangreco AA, Li D, Dias A, Cardoza M, Laszlo S, Hersey K, Klotz L, Finelli A, Fleshner N, Vieth R, Department of Nutritional Sciences, University of Toronto, Ontario, Canada.: J Clin Endocrinol Metab 2013;98(4):1498-507 [Epub 2013 Mar 5].
    Olumi AF
    Urol Oncol; 2014 Feb; 32(2):210. PubMed ID: 24445291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study.
    Brändstedt J; Almquist M; Ulmert D; Manjer J; Malm J
    Cancer Causes Control; 2016 Jan; 27(1):69-80. PubMed ID: 26518197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.
    Young MV; Schwartz GG; Wang L; Jamieson DP; Whitlatch LW; Flanagan JN; Lokeshwar BL; Holick MF; Chen TC
    Carcinogenesis; 2004 Jun; 25(6):967-71. PubMed ID: 14729578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and prostate cancer risk: a review of the epidemiological literature.
    Gupta D; Lammersfeld CA; Trukova K; Lis CG
    Prostate Cancer Prostatic Dis; 2009; 12(3):215-26. PubMed ID: 19350051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy.
    Woo TC; Choo R; Jamieson M; Chander S; Vieth R
    Nutr Cancer; 2005; 51(1):32-6. PubMed ID: 15749627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and prostate cancer.
    Feldman D; Skowronski RJ; Peehl DM
    Adv Exp Med Biol; 1995; 375():53-63. PubMed ID: 7645428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer.
    Varsavsky M; Reyes-García R; Cortés-Berdonces M; García-Martin A; Rozas-Moreno P; Muñoz-Torres M
    Endocrinol Nutr; 2011 Nov; 58(9):487-91. PubMed ID: 22014882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.
    Dambal S; Giangreco AA; Acosta AM; Fairchild A; Richards Z; Deaton R; Wagner D; Vieth R; Gann PH; Kajdacsy-Balla A; Van der Kwast T; Nonn L
    J Steroid Biochem Mol Biol; 2017 Mar; 167():192-202. PubMed ID: 28089917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.